Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

183 Views

Poster Session: Public Health

1361 - Lyme Borreliosis (LB) is a Significant Disease Burden in Germany: Estimated LB Incidence after Adjusting for Under-ascertainment by Public Health Surveillance, 2021

Friday, October 21, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

The ePoster content is available to users who are logged in.<br><br>Please click the login button at the top right corner and then come back here to use this button.

Co-Author(s)

JO

Julia Olsen, BS

Pfizer Vaccines
Collegeville, Pennsylvania, United States
GB

Gordon Brestrich, PhD

Pfizer Vaccines
Berlin, Berlin, Germany
AP

Andreas Pilz, PhD

Director
Pfizer Corporation Austria
Vienna, Wien, Austria
KH

Kate Halsby, PhD

Pfizer Inc
London, England, United Kingdom
PK

Patrick Kelly, PhD

Pfizer Vaccines
Collegeville, Pennsylvania, United States
CM

Claudius Malerczyk, PhD

Pfizer Vaccines
Berlin, Berlin, Germany

Presenting Author(s)

Frederick Angulo, DVM PhD

Lead, Scientific Affairs
Pfizer Vaccines
Collegeville, Pennsylvania, United States

Co-Author(s)

JS

James H. Stark, PhD

Medical Study Lead, Senior Director
Pfizer Biopharma Group
Collegeville, Pennsylvania, United States